Filter
Period
Filter by
recent search
Showing: 1 – 05 of 152 Regulated Information
–
08 September 2023
08 September 2023
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rightsand shares composing the share capital
–
05 September 2023
05 September 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 35 – 2023
Aggregated presentation by day and by market
–
04 September 2023
04 September 2023
Ipsen nominates Pascal Touchon to its Board of Directors as new independent director
PARIS, FRANCE, 4 September 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Pascal Touchon to its Board as an independent director, effective 4 October 2023, following the decision of Paul Sekhri to step down from his…
–
01 September 2023
01 September 2023
Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet
PARIS, FRANCE, 1 September 2023 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of Research and Development. She will succeed Howard Mayer, EVP and Head…
–
29 August 2023
29 August 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 34 – 2023
Aggregated presentation by day and by market